Vaxess Technologies
David Miller has over 30 years of work experience. David started their career in 1988 as an Associate Scientist at Hygeia Sciences, Inc. David then moved to T Cell Sciences, Inc. in 1990, where they held the role of Senior Associate Scientist in Research Monoclonal Antibody Development. In 1993, they joined AVANT Immunotherapeutics, Inc. as a Scientist in Cell Biology & Discovery Research, and was later promoted to Supervisor of Clinical Assays and Senior Scientist I in Cell Biology & Discovery Research. In 2005, they joined ARIAD Pharmaceuticals, Inc. as a Research Scientist I in Translational Biology & Clinical Assays, and was later promoted to Research Scientist II in Translational Biology. In 2014, they joined Vaxess Technologies as a Senior Scientist, and was later promoted to Manager of Lab Operations and Principal Scientist.
David Miller attended Massasoit Community College from 1983 to 1985, where they earned an Associate of Arts (AA) in Liberal Arts. David then attended Boston University from 1985 to 1988, where they earned a Bachelor of Arts (BA) in Psychology.
Vaxess Technologies
Vaxess Technologies is a venture capital and Gates Foundation-backed life science company developing novel vaccine formulations and delivery technologies based on its proprietary silk platform. They are committed to improving access to vaccines by enabling better, more stable vaccine products that can be easily delivered all over the world.